Mark Erlander Net Worth & Insider Trades

Mark Erlander - Chief Executive Officer, Cardiff Oncology, Inc

As of March 10, 2022

What is Mark Erlander's Net Worth?

The current estimated net worth of Cardiff Oncology, Inc's Chief Executive Officer, Mark Erlander, is estimated to be about $0 . Mark Erlander owns about 14,481 units of Cardiff Oncology, Inc common stock. In the last 2 years at Cardiff Oncology, Inc, Mark Erlander has sold an estimated value of $0 worth.

What is Mark Erlander's Past Insider Trading?

Mark Erlander's largest purchase order was 6,993 units , worth over $10K on May 18, 2020. In total, Mark Erlander has made about 6 transactions over 2 years of their time at Cardiff Oncology, Inc. Mark Erlander usually trades in March and June, with the busiest year in 2021. The most recent transaction was a purchase order of 965 units , worth over $9.98K on March 23, 2021.

Mark Erlander

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Mark Erlander's' Mailing Address?

  • Mailing address is C/o Trovagene, Inc. 11055 Flintkote Avenue, Suite A San Diego CA 92121 CA

What are Cardiff Oncology, Inc's Past Insider Trades?

Cardiff Oncology, Inc's most recent insider trade came on October 11, 2022 by James Armitage who bought 13,000 units worth $20.23K . In the last 2 years, insiders at Cardiff Oncology, Inc have sold an estimated value of $657.02K and bought an estimated value of $2.05M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Gary Pace, Director,  James Armitage, Director,  and John Brancaccio .

Cardiff Oncology, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1